• Led a team of three scientists that performed analytical testing, development and validation of drug entities and excipients.• Ensured team’s accordance with industry standard cGMP and ICH guidelines and procedures.• Acted as the Division lead and subject matter expert during the deployment of the new Empower 3 chromatography data software package.• Developed new analytical test methods, standard operating procedures, and instrument operating procedures in support of team performance.• Served as a trainer and advisor to seven junior chemists, including conducting annual performance reviews.

• Led team of five chemists that developed and validated new analytical methods for new potential Cancer treatment drug entities. The team’s work towards the development of successful breakthrough treatments helped lead to the eventual company sale for $1B+, a roughly 10x valuation vs. current company market cap.• Authored new standard operating procedures, validation protocols and test methods for on-going Quality Assurance of potential new drug entities.• Served as the lead architect for the deployment of the Empower 3 chromatography data directory, a company-wide program used to gather R&D and quality control data for oncology drugs.• Mentored four new chemists and served as a trainer for multiple analytical techniques.

• Served as the lead compounding chemist during manufacturing operations for parenteral and ophthalmic drugs, netting the company approximately $50 million in revenue.• Developed over fifty new laboratory methods and validation procedures for quality control in support of twenty separate product lines.• Led the purchase of a $500,000 capital equipment buy for the R&D and QC departments, from initial project justification through equipment installation.• Trained, mentored, and performed data review for thirteen fellow scientists within the R&D and QC departments.

• Conducted 3rd party testing and analysis of inhalable, ingestible, and other pharmaceutical products that generated several million dollars of annual revenue for the company.• Performed test method validations following industry standard cGMP and ICH guidelines. Authored method validation reports for internal company use for future testing.• Performed data review on fellow analysts' notebooks, analyses, and loose data records for method validations and stability testing.

• Managed a lab of four employees in the development and validation of HPLC methods for over 100 pharmaceutical ingredients and finished drug products used in three generations of a medical diagnostic platform. Sales of platform and consumables have exceeded $50 million to date.• Managed an annual lab budget of $500,000 for capital equipment purchase and expenditures.• Provided product and in-process support testing for five separate product lines.• Performed preventative and corrective maintenance on lab instrumentation.Developed novel amperometric waveforms for direct detection of aminoglycosides and macrolides.Performed preventative and corrective maintenance on HPLC and LC/MS systems.

• Served during Operations Desert Storm and Operation Enduring Freedom.• Completed tours of duty onboard USS Dale (CG-19) and USS George Washington (CVN-73), including leading a repair shop of six sailors.• Served a two-year expatriate assignment in Keflavik, Iceland in a Military Police unit.